
Surmodics SRDX
Quartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Surmodics P/E 2011-2026 | SRDX
P/E Jährlich Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -48 | -313 | -18.6 | 146 | 628 | 82.8 | -188 | 98.4 | 32.6 | 23.3 | 24.5 | 23.1 | 32.2 | -14.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 628 | -313 | 36.3 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
34.7 | $ 114.84 | -0.55 % | $ 34.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.3 | 0.62 % | $ 175 M | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Biodesix
BDSX
|
-2.14 | $ 15.36 | 1.92 % | $ 1.99 B | ||
|
Koninklijke Philips N.V.
PHG
|
9.27 | $ 27.2 | 0.33 % | $ 20 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 17.82 | -2.68 % | $ 950 M | ||
|
Anixa Biosciences
ANIX
|
-0.00947 | $ 2.59 | 1.57 % | $ 84.1 K | ||
|
Biomerica
BMRA
|
-1.45 | $ 2.17 | - | $ 4.98 M | ||
|
BioNano Genomics
BNGO
|
-0.301 | $ 1.15 | -4.17 % | $ 6.26 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 168.22 | -3.26 % | $ 8.34 B | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 24.73 | -0.44 % | $ 687 M | ||
|
Celcuity
CELC
|
-30.3 | $ 114.22 | 1.41 % | $ 5.34 B | ||
|
Danaher Corporation
DHR
|
41.4 | $ 192.12 | 0.53 % | $ 137 B | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
DexCom
DXCM
|
30.5 | $ 63.21 | 1.59 % | $ 24.7 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 198.96 | 0.91 % | $ 22.1 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 16.42 | -2.38 % | $ 496 M | ||
|
Guardant Health
GH
|
-32.3 | $ 89.66 | -4.44 % | $ 11.2 B | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 109.62 | -4.0 % | $ 9.04 B | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.97 | 0.63 % | $ 8.72 M | ||
|
Illumina
ILMN
|
-13.4 | $ 127.74 | 0.28 % | $ 20.3 B | ||
|
IQVIA Holdings
IQV
|
20.8 | $ 170.72 | -1.47 % | $ 29.3 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 274.46 | 0.27 % | $ 22.8 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 75.89 | -0.28 % | $ 5.12 B | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 496.0 | -0.47 % | $ 14.3 B | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 266.63 | 0.53 % | $ 26.1 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.67 | -1.68 % | $ 432 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.521 | $ 4.74 | 1.07 % | $ 3.73 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 8.02 | 0.25 % | $ 1.03 B | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 9.56 | 1.59 % | $ 2.07 B | ||
|
National Research Corporation
NRC
|
27.2 | $ 17.33 | 0.99 % | $ 388 M |